Vir Biotechnology (VIR) Shares Outstanding (2018 - 2026)

Vir Biotechnology has disclosed Shares Outstanding across 9 years of filings, most recently posting $161.2 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $161.2 million, up 16.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $161.2 million (up 16.78% YoY), and the FY2025 annual result was $139.5 million, up 1.84% from the prior year.
• Shares Outstanding came in at $161.2 million for Q1 2026 at Vir Biotechnology, up from $139.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $161.2 million in Q1 2026 to a low of $132.4 million in Q1 2022.
• The 5-year median for Shares Outstanding is $135.8 million (2024), against an average of $137.1 million.
• Across the five-year window, Shares Outstanding rose 1.11% in 2023 and grew 16.78% in 2026, its largest moves.
• Vir Biotechnology's Shares Outstanding stood at $133.2 million in 2022, then increased by 1.16% to $134.8 million in 2023, then grew by 1.62% to $137.0 million in 2024, then grew by 1.84% to $139.5 million in 2025, then grew by 15.6% to $161.2 million in 2026.
• The last three Shares Outstanding figures came in at $161.2 million (Q1 2026), $139.5 million (Q4 2025), and $139.0 million (Q3 2025), per Business Quant data.